Zhang Pengcheng, Pei Yuhan, Zhi Yunlai, Sun Fanghu, Song Ninghong
Department of Urology, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, 6 Zhenhua East Road, Lianyungang, 222000, China.
The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
BMC Surg. 2025 Jan 6;25(1):6. doi: 10.1186/s12893-024-02746-z.
Investigating the application of single-port single-channel and single-port multi-channel adrenalectomy in various maximum tumor diameters.
Retrospective analysis of clinical data from 218 adrenal tumors treated with single-port retroperitoneoscopic adrenalectomy at Lianyungang Clinical Medical College of Nanjing Medical University from September 2018 to November 2023. All adrenal tumors are benign lesions classified as T1 stage. Tumors were classified into three groups based on their maximum diameter: ≤3 cm (Group A), >3 cm and ≤ 4 cm (Group B), and > 4 cm and ≤ 5 cm (Group C). Based on the surgical approach, patients were divided into single-port single-channel and single-port multi-channel groups. Group A had an average tumor diameter of (2.32 ± 0.45) cm with 46 single-port single-channel and 53 single-port multi-channel cases; Group B had (3.42 ± 0.31) cm with 33 single-port single-channel and 45 single-port multi-channel cases; Group C had (4.60 ± 0.28) cm with 18 single-port single-channel and 23 single-port multi-channel cases. Comparisons were made between single-port single-channel and single-port multi-channel groups in terms of operation time, hospital stay, intraoperative bleeding, postoperative pain score, surgical complications, incision length (total length of all incisions), and the need for additional puncture holes for each tumor size group.
All 218 surgeries were successfully completed without conversion to open surgery. In Group A, no significant difference was observed between single-channel and multi-channel groups in terms of operation time and blood loss (P > 0.05), but significant differences were found in hospital stay, pain score, subcutaneous emphysema incidence, and incision length (P < 0.05). In Group B, there was no significant difference between single-channel and multi-channel groups regarding operation time and blood loss (P > 0.05), but significant differences were observed in hospital stay, pain score, subcutaneous emphysema incidence, and incision length (P < 0.05). In Group C, no significant difference was observed between single-channel and multi-channel groups in terms of hospital stay, blood loss, pain score, incision length, vascular injury, and subcutaneous emphysema incidence (P > 0.05), but significant differences were found in operation time and the incidence of additional puncture holes (P < 0.05). Postoperative follow-up ranged from 4 to 22 months, with an average of 11.5 months, and no complications were observed.
Single-port single-channel laparoscopy has significant advantages in surgeries for tumors with a maximum diameter ≤ 4 cm, as it can directly reach the target organ, reduce separation operations, cause less damage, and has good cosmetic effects. For adrenal tumor surgeries with a maximum diameter > 4 cm, the multi-channel technique is superior to the single-channel technique in terms of shorter hospital stay and the need for additional punctures.
探讨单孔单通道与单孔多通道肾上腺切除术在不同最大肿瘤直径中的应用。
回顾性分析2018年9月至2023年11月在南京医科大学附属连云港临床医学院接受单孔后腹腔镜肾上腺切除术治疗的218例肾上腺肿瘤患者的临床资料。所有肾上腺肿瘤均为T1期良性病变。根据肿瘤最大直径将肿瘤分为三组:≤3 cm(A组)、>3 cm且≤4 cm(B组)、>4 cm且≤5 cm(C组)。根据手术方式,将患者分为单孔单通道组和单孔多通道组。A组肿瘤平均直径为(2.32±0.45)cm,单孔单通道组46例,单孔多通道组53例;B组为(3.42±0.31)cm,单孔单通道组33例,单孔多通道组45例;C组为(4.60±0.28)cm,单孔单通道组18例,单孔多通道组23例。比较单孔单通道组和单孔多通道组在手术时间、住院时间、术中出血量、术后疼痛评分、手术并发症、切口长度(所有切口总长度)以及各肿瘤大小组额外穿刺孔需求方面的差异。
218例手术均顺利完成,无一例转为开放手术。A组中,单通道组与多通道组在手术时间和出血量方面无显著差异(P>0.05),但在住院时间、疼痛评分、皮下气肿发生率和切口长度方面存在显著差异(P<0.05)。B组中,单通道组与多通道组在手术时间和出血量方面无显著差异(P>0.05),但在住院时间、疼痛评分、皮下气肿发生率和切口长度方面存在显著差异(P<0.05)。C组中,单通道组与多通道组在住院时间、出血量、疼痛评分、切口长度、血管损伤和皮下气肿发生率方面无显著差异(P>0.05),但在手术时间和额外穿刺孔发生率方面存在显著差异(P<0.05)。术后随访4至22个月,平均11.5个月,未观察到并发症。
单孔单通道腹腔镜手术在最大直径≤4 cm的肿瘤手术中具有显著优势,可直接到达靶器官,减少分离操作,损伤小,美容效果好。对于最大直径>4 cm的肾上腺肿瘤手术,多通道技术在缩短住院时间和减少额外穿刺需求方面优于单通道技术。